AUROBINDO PHARMA Plunges by 5%; BSE HEALTHCARE Index Down 1.0%
May 17, 2019 09:32 AM

AUROBINDO PHARMA share price has plunged 5% and is presently trading at Rs 725.

Meanwhile, the BSE HEALTHCARE Index is at 13,328 (down 1.0%).

Among the top losers in the BSE HEALTHCARE Index today is AUROBINDO PHARMA (down 5.1%).

NARAYANA HRUDAYALAYA LTD (up 1.8%) and SHILPA MEDICARE (up 1.3%) are among the top gainers today.

Over the last one year, AUROBINDO PHARMA has moved up from Rs 603 to Rs 725, registering a gain of Rs 122 (up 20.3%)..

The BSE HEALTHCARE has moved up from 13,285 to 13,328, registering a gain of 43 points (up 0.3%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 39.6%), DR. REDDYS LAB (up 38.1%) and SUVEN LIFESCIENCES (up 32.7%).

What About the Benchmark Indices?

The BSE Sensex is at 37,608 (up 0.5%). The top gainers among the BSE Sensex stocks today are YES BANK (up 5.3%). The most traded stocks in the BSE Sensex are YES BANK and SBI.

In the meantime, NSE Nifty is at 11,315 (up 0.3%). YES BANK (up 4.9%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,388 to 37,608, registering a gain of 2,220 points (up 6.2%).

AUROBINDO PHARMA Financial Update...

AUROBINDO PHARMA net profit stood at Rs 7 billion for the quarter ended December 2018, compared to a profit of Rs 6 billion a year ago. Net Sales rose 21.5% to Rs 52.7 billion during the period as against Rs 43.4 billion in October-December 2017.

For the year ended March 2018, AUROBINDO PHARMA reported 5.4% increase in net profit to Rs 24.2 billion compared to net profit of Rs 23.0 billion during FY17.

Revenue of the company grew 9.3% to Rs 165 billion during FY18.

The current Price to earnings ratio of AUROBINDO PHARMA, based on rolling 12 month earnings, stands at 17.5x.